FDA Adverse Event Injury Summary report: N

INVIA MOTION+ ENDURE SINGLE

MDR report key: 9801302 · Received March 6, 2020

Report

Report Number
1419937-2020-00020
Event Type
Injury
Date Received
March 6, 2020
Date of Event
February 5, 2020
Manufacturer
MEDELA AG
Product Code
OMP
PMA / PMN Number
K142626
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MEDELA LLC FOLLOWED-UP WITH CLINICIANS AT THE HEALTHCARE FACILITY. THE RESULTS OF THOSE INTERVIEWS INDICATE NORMAL WOUND DRAINAGE AND NO SIGNS OF SWELLING, REDNESS OR ADVERSE REACTION UPON REMOVAL OF THE MEDELA DEVICE. THE PRODUCT INFORMATION WAS REVIEWED AND THE CONTACT MATERIAL (FOAM AND TRANSPARENT FILM) WAS REVIEWED DURING THE DESIGN PROCESS FOR CYTOTOXICITY AND SENSITIVITY PER ISO10993-5 AND ISO10993-10, RESPECTIVELY, AND WAS DETERMINED TO HAVE MET ALL REQUIREMENTS. ADDITIONALLY, WHEN REVIEWING THE LOT INFORMATION FOR THE DRESSING SET, IT WAS DETERMINED THAT THERE WERE NO DEVIATIONS, STERILITY WAS PROVEN, AND LAL TESTING WAS COMPLETED WITH PRODUCT MEETING THE REQUIREMENTS FOR IMPLANTABLE DEVICES. THE MOTION ENDURE NEGATIVE PRESSURE WOUND THERAPY DEVICE WAS DESIGNED AND MANUFACTURED MEETING ALL SPECIFICATIONS.

Description of Event or Problem · 1

ON (B)(6) 2020, A DISTRIBUTOR REPRESENTATIVE REPORTED TO MEDELA LLC THAT A NEGATIVE PRESSURE WOUND THERAPY DEVICE WAS PLACED ON PATIENT ON (B)(6) 2020 AND APPROXIMATELY 15-20 MINUTES AFTER PLACEMENT, THE PATIENT EXPRESSED COMPLAINTS RELATED TO PAIN (6 OUT OF 10), REDNESS AND SWELLING. ADDITIONALLY, THE PATIENT DISPLAYED SIGNS OF INCREASED ANXIETY. THE HEALTHCARE FACILITY CASE MANAGER REPORTED TO THE DISTRIBUTOR REPRESENTATIVE THAT THE PATIENT HAD A REACTION AFTER THE NEGATIVE PRESSURE WOUND THERAPY DEVICE WAS PLACED ON THE WOUND.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
265394 INVIA MOTION+ ENDURE SINGLE NEGATIVE PRESSURE WOUND THERAPY POWERED SUCTION PUMP OMP MEDELA AG 0874010 NI

Patients

Seq Age Sex Outcome Treatment
1 Other